FDA warning letter surrounding herpes products underscores potential misuse of AI
Claudia Adrien
Interview
A U.S. Food and Drug Administration warning letter issued earlier this year is continuing to spur conversation about the appropriate use of AI to comply with the agency’s regulations.
